Project Connect
Connecting with friends
Staying connected, especially during recent times, has been very difficult for people living with Multiple Sclerosis (MS). Thanks to our donors we are bringing back “Project Connect.” MSSP will provide new iPads to those diagnosed with MS in Oregon and SW Washington. Some restrictions apply. For more information, contact us at 503 297-9544 or email us at info@msoregon.org. A completed application along with proof of diagnosis is required. iPads will be given on a first-come, first-serve basis as resources permit.
Application Instructions
In order to apply, you will need to provide documentation of your MS diagnosis. This can be either a medical chart note that includes your name and diagnosis, SSI/SSDI verification or the cardboard cover off of one of the following medications:
Injectable medications
Avonex® (interferon beta-1a)
Betaseron® (interferon beta-1b)
Copaxone® (glatiramer acetate)
Extavia® (interferon beta-1b)
Glatopa® (glatiramer acetate—generic of Copaxone)
Plegridy® (peginterferon beta-1a)
Glatopa (glatiramer acetate – generic equivalent of Copaxone 20mg and 40mg doses)
Rebif® (interferon beta-1a)
Kesimpta® (ofatumumab)
Oral medications
Aubagio® (teriflunomide)
Bafiertam™ (monomethyl fumarate)
Dimethyl Fumarate (dimethyl fumarate – generic equivalent of Tecfidera)
Gilenya® (fingolimod)
Mavenclad® (cladribine)
Mayzent® (siponimod)
Tecfidera® (dimethyl fumarate)
Vumerity® (diroximel fumarate)
Zeposia® (ozanimod)
Infused medications
Lemtrada® (alemtuzumab)
Novantrone® (mitoxantrone)
Ocrevus® (ocrelizumab)
Tysabri® (natalizumab)